Institute for Memory Impairment & Neurological Disorders

Irvine, California 92697

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Cognition Disorders

Studies at this site

• Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss — Completed
• A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ) — Completed
• Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo — Stopped early